2026年6月1日 · 自动抓取 · 最新研究 · 1 分钟阅读

Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationwide registry analysis

Blood Cancer Journal, Published online: 01 June 2026; doi:10.1038/s41408-026-01534-7Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationw

本文自动抓取自 Blood Cancer Journal，原文链接：Prognostic impact of morphological lymphocyte counts on aggressive adult T-cell leukemia/lymphoma: Japan ATL nationwide registry analysis

原文发布日期：2026-06-01

Back to Blog

View All Posts »

Detection of <i>MEN1</i> resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors

Blood Cancer Journal, Published online: 16 June 2026; doi:10.1038/s41408-026-01545-4Detection of MEN1 resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors

D-VRD induction and autologous transplant in patients ≥70 years

Blood Cancer Journal, Published online: 05 June 2026; doi:10.1038/s41408-026-01522-xD-VRD induction and autologous transplant in patients ≥70 years

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

Blood Cancer Journal, Published online: 03 June 2026; doi:10.1038/s41408-026-01533-8Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis

Blood Cancer Journal, Published online: 02 June 2026; doi:10.1038/s41408-026-01531-wChimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with mult

Related Posts

Detection of <i>MEN1</i> resistance mutations in cell-free DNA from acute leukemia patients treated with menin inhibitors

D-VRD induction and autologous transplant in patients ≥70 years

Survival trends in the era of novel therapies identify unmet needs in peripheral T-cell lymphoma: a national cancer database analysis

Chimeric antigen receptor T-cell therapy is equally effective and safe in older (≥70) and younger patients with multiple myeloma: a multicenter retrospective analysis